n.a. (VPHM)

49.96
0.01 0.02
NASDAQ
Prev Close 49.97
Open 49.98
Day Low/High 49.96 / 50.01
52 Wk Low/High 0.00 / 0.00
Volume 4.78M
Exchange NASDAQ
Shares Outstanding 65.97M
Market Cap 3.30B
Div & Yield N.A. (N.A)

Latest News

VIROPHARMA, INC. INVESTOR ALERT: The Law Offices Of Vincent Wong Investigates The Sale Of ViroPharma, Inc. To Shire PLC -- VPHM

VIROPHARMA, INC. INVESTOR ALERT: The Law Offices Of Vincent Wong Investigates The Sale Of ViroPharma, Inc. To Shire PLC -- VPHM

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of ViroPharma, Inc.

VIROPHARMA INVESTOR ALERT: Faruqi & Faruqi, LLP Is Investigating The ViroPharma Inc. Board Of Directors For Possible Breaches Of Fiduciary Duty In Connection With Proposed Sale Of The Company To Shire PLC

VIROPHARMA INVESTOR ALERT: Faruqi & Faruqi, LLP Is Investigating The ViroPharma Inc. Board Of Directors For Possible Breaches Of Fiduciary Duty In Connection With Proposed Sale Of The Company To Shire PLC

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ViroPharma Inc.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of ViroPharma, Inc.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of ViroPharma, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ViroPharma, Inc.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of ViroPharma Incorporated Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of ViroPharma Incorporated Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of ViroPharma Incorporated (“ViroPharma” or the “Company”) (NASDAQ:VPHM) concerning the proposed acquisition of the...

VIROPHARMA, INC. INVESTOR ALERT: The Law Offices Of Vincent Wong Investigates The Sale Of ViroPharma, Inc. To Shire PLC -- VPHM

VIROPHARMA, INC. INVESTOR ALERT: The Law Offices Of Vincent Wong Investigates The Sale Of ViroPharma, Inc. To Shire PLC -- VPHM

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of ViroPharma, Inc.

VIROPHARMA INCORPORATED INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of ViroPharma Inc. (VPHM) Over The Proposed Sale Of The Company To Shire (SHPG)

VIROPHARMA INCORPORATED INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of ViroPharma Inc. (VPHM) Over The Proposed Sale Of The Company To Shire (SHPG)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ViroPharma Inc.

Market Up on Deals, Results

Market Up on Deals, Results

Markets edged higher as some stocks jumped on deal making, with key retailer results to be closely watched this week.

ViroPharma Larger Than S&P 500 Component JDS Uniphase

ViroPharma Larger Than S&P 500 Component JDS Uniphase

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component ViroPharma Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example JDS Uniphase Corp , according to The Online Investor.

SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation Of Possible Breaches Of Fiduciary Duty By Directors Of ViroPharma Incorporated In Connection With Proposed Buyout

SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation Of Possible Breaches Of Fiduciary Duty By Directors Of ViroPharma Incorporated In Connection With Proposed Buyout

The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of ViroPharma Incorporated ...

Finkelstein Thompson LLP Announces Investigation Of ViroPharma Inc. Buyout Proposal

Finkelstein Thompson LLP Announces Investigation Of ViroPharma Inc. Buyout Proposal

The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ViroPharma Inc.

Shire Deal Just The Start

Shire Deal Just The Start

Shire's purchase of ViroPharma is a signal of deals and higher prices ahead, says Jason Kolbert, Sr. Research Analyst at the Maxim Group.

ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Shire

ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Shire

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of ViroPharma...

VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of ViroPharma Inc. (VPHM) Over The Proposed Sale Of The Company To Shire (SHPG) In A Cash Deal

VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of ViroPharma Inc. (VPHM) Over The Proposed Sale Of The Company To Shire (SHPG) In A Cash Deal

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ViroPharma Inc.